Jane Street’s Achieve Life Sciences ACHV Stock Holding History

Jane Street’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$519K	Sell	176,600 -205,611	-54%	-$913K	﹤0.01%	7965
2025 Q4	$1.9M	Buy	+382,211	New	+$1.67M	﹤0.01%	4910
2025 Q3	–	Sell	-70,452	Closed	-$193K	–	10662
2025 Q2	$159K	Buy	+70,452	New	+$201K	﹤0.01%	8706
2024 Q4	–	Sell	-14,891	Closed	-$70.6K	–	9271
2024 Q3	$70.6K	Buy	+14,891	New	+$68K	﹤0.01%	9098
2022 Q4	–	Sell	-16,082	Closed	-$53K	–	9020
2022 Q3	$53K	Buy	+16,082	New	+$76.7K	﹤0.01%	8901
2019 Q3	–	Sell	-842	Closed	-$32K	–	4991
2019 Q2	$32K	Buy	+842	New	+$59.5K	﹤0.01%	4993
2013 Q3	–	Sell	-25	Closed	-$542K	–	2660
2013 Q2	$542K	Buy	+25	New	+$559K	0.01%	1377

Other funds holding ACHV

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's ACHV Position: Q1 2026 in Review

Jane Street reduced its Achieve Life Sciences (ACHV) stake by 54% in Q1 2026, selling an estimated $913K and leaving 176,600 shares worth $519K. The position accounts for ﹤0.01% of the portfolio, ranked #7965.

Jane Street first reported a position in ACHV in Q2 2013 and has held it in 7 quarters since. The position peaked at $1.9M in Q4 2025. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

Jane Street held 176,600 shares of Achieve Life Sciences worth $519K as of Q1 2026.
Jane Street sold 205,611 Achieve Life Sciences shares in Q1 2026, an estimated $913K.
Achieve Life Sciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7965 holding.
Jane Street first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 7 quarters since.
Jane Street's Achieve Life Sciences position peaked at $1.9M in Q4 2025.
81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.